The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais

Journal of Clinical Biochemistry and Nutrition

Volumn 44, Issue 1, 2009, Pages 104-110

  Suriyaprom, Kanjana ^a   Phonrat, Benjaluck ^b   Namjuntra, Pisit ^a   Chanchay, Siriporn ^c   Tungtrongchitr, Rungsunn ^b  

^a RANGSIT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c BURAPHA UNIVERSITY   (Thailand)

Author keywords

+299(G>A) resistin gene polymorphism; Type 2 diabetes

Indexed keywords

ADENINE; ADIPOCYTOKINE; CYTOSINE; GLUCOSE; GUANINE; INSULIN; RESISTIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

THAIS;

EID: 60849115832     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-224     Document Type: Article

References (28)

1. Conneely, K.N., Silander, K., Scott, L.J., Mohlke, K.L., Lazaridis, K.N., Valle, T.T., Tuomilehto, J., Bergman, R.N., Watanabe, R.M., Buchanan, T.A., Collins, F.S., and Boehnke, M.: Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia, 47, 1782-1788, 2004.
2. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., and Lazar, M.A.: The hormone resistin links obesity to diabetes. Nature, 409, 307-312, 2001.
3. Kim, K.H., Lee, K., Moon, Y.S., and Sul, H.S.: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem., 276, 11252-11256, 2001.
4. Danforth, E. Jr.: Failure of adipocyte differentiation causes type II diabetes mellitus? Nat. Genet., 26, 13, 2000.
5. McGarry, J.D.: Dysregulation of fatty acid metabolism in the etiology of type-2 diabetes. Diabetes, 51, 7-18, 2002.
6. Degawa-Yamauchi, M., Bovenkerk, J.E., Juliar, B.E., Watson, W., Kerr, K., Jones, R., Zhu, Q., and Considine, R.V.: Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab., 88, 5452-5455, 2003.
7. McTernan, P.G., Fisher, F.M., Valsamakis, G., Chetty, R., Harte, A., McTernan, C.L., Clark, P.M., Smith, S.A., Barnett, A.H., and Kumar, S.: Resistin and type-2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab., 88, 6098-6106, 2003.
8. Lee, J.H., Chan, J.L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C., and Mantzoros, C.S.: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: crosssectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab., 88, 4848-4856, 2003.
9. Utzschneider, K.M., Carr, D.B., Tong, J., Wallace, T.M., Hull, R.L., Zraika, S., Xiao, Q., Mistry, J.S., Retzlaff, B.M., Knopp, R.H., and Kahn, S.E.: Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia, 48, 2330-2333, 2005.
10. Gerber, M., Boettner, A., Seidel, B., Lammert, A., Bär, J., Schuster, E., Thiery, J., Kiess, W., and Kratzsch, J.: Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab., 90, 4503-4509, 2005.
11. Osawa, H., Yamada, K., Onuma, H., Murakami, A., Ochi, M., Kawata, H., Nishimiya, T., Niiya, T., Shimizu, I., and Nishida, W.: The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type-2 diabetes mellitus susceptibility by inducing p2004; romoter activity through specific binding of Sp1/3. Am. J. Hum. Genet., 75, 678-686, 2004.
12. Ma, X., Warram, J.H., Trischitta, V., and Doria, A.: Genetic variants at the resistin locus and risk of type-2 diabetes in Caucasians. J. Clin. Endocrinol. Metab., 87, 4407-4410, 2002.
13. Ochi, M., Osawa, H., Onuma, H., Murakami, A., Nishimiya, T., Shimada, F., Kato, K., Shimizu, I., Shishino, K., Murase, M., Fujii, Y, Ohashi, J., and Makino, H.: The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type-2 diabetes. Diabete. Res. Clin. Pract., 61, 191-198, 2003.
14. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 31, S55-S60, 2008.
15. Kunnari, A., Ukkola, O., and Kesäniemi, Y.A.: Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet. Med., 22, 583-589, 2005.
16. Michael, W., Obici, S., Scherer, P.E., and Rossetti, L.: Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest., 111, 225-230, 2003.
17. Fasshauer, M. and Paschke, R.: Regulation of adipocytokines and insulin resistance. Diabetologia, 46, 1594-1603, 2003.
18. McTernan, C.L., McTernan, P.G., Harte, A.L., Levick, P.L., Barnett, A.H., and Kumar, S.: Resistin, central obesity, and type-2 diabetes. Lancet, 359, 46-47, 2002.
19. Fujinami, A., Obayashi, H., Ohta, K., Ichimura, T., Nishimura, M., Matsui, H., Kawahara, Y., Yamazaki, M., Ogata, M., Hasegawa, G., Nakamura, N., Yoshikawa, T., Nakano, K., and Ohta, M.: Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type-2 diabetes. Clin. Chim. Acta, 339, 57-63, 2004.
20. Fehmann, H.C. and Heyn, J.: Plasma resistin levels in patients with Type 1 and Type-2 diabetes mellitus and in healthy controls. Horm. Metab. Res., 34, 671-673, 2002.
21. Stejskal, D., Adamovská, S., Bartek, J., Juráková, R., and Prosková, J.: Resistin concentrations in persons with type-2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac. Palacky. Univ., Olomouc., 147, 63-69, 2003.
22. Urbanek, M., Du, Y., Silander, K., Collins, F.S., Steppan, C.M., Strauss, J.F. 3rd., Spielman, R.S., and Legro, R.S.: Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes, 52, 214-217, 2003.
23. Engert, J.C., Vohl, M.C., Williams, S.M., Lepage, P., Loredo-Osti, J.C., Faith, J., Doré, C., Renaud, Y., Burtt, N.P., Villeneuve, A., Hirschhorn, J.N., Altshuler, D., Groop, L.C., Després, J.P., Gaudet, D., and Hudson, T.J.: 5′ flanking variants of resistin are associated with obesity. Diabetes, 51, 1629-1634, 2002.
24. Pesole, G., Mignone, F., Gissi, C., Grillo, G., Licciulli, F., and Liuni, S.: Structural and functional features of eukaryotic mRNA untranslated regions. Gene, 276, 73-81, 2001.
25. Tsukada, S., Tanaka, Y., Maegawa, H., Kashiwagi, A., Kawamori, R., and Maeda, S.: Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol. Endocrinol., 20, 1104-1111, 2006.
26. Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., and Araki, E.: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes, 52, 2570-2577, 2003.
27. Manabe, E., Handa, O., Naito, Y., Mizushima, K., Akagiri, S., Adachi, S., Takagi, T., Kokura, S., Maoka, T., and Yoshikawa, T.: Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J. Cell Biochem., 103, 1925-1937, 2008.
28. Kanetkar, P., Singhal, R., and Kamat, M.: Gymnema sylvestre: A Memoir. J. Clin. Biochem. Nutr., 41, 77-81, 2007.